CIK: 0001440771 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $237,711 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AMRYT PHARMA PLC - SPNR ADR | 6,333,239 | $46,233 | 19.4% | $12.34 | — | SPONSORED ADS | 03217L106 |
| — | APOLLO ENDOSURGERY INC | 3,726,584 | $37,154 | 15.6% | $6.44 | — | COM | 03767D108 |
| — | CTI BIOPHARMA CORP | 4,934,100 | $29,654 | 12.5% | $3.66 | — | COM | 12648L601 |
| ADMA | ADMA BIOLOGICS INC | 6,940,000 | $26,927 | 11.3% | $1.81 | +70.5% | COM | 000899104 |
| QDEL | QUIDELORTHO CORP | 300,000 | $25,701 | 10.8% | $92.45 | -8.4% | COM | 219798105 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 11,195,189 | $14,890 | 6.3% | $2.15 | -34.2% | COM | 98422E103 |
| URGN | UROGEN PHARMA LTD | 1,304,947 | $11,575 | 4.9% | $7.43 | +27.4% | COM | M96088105 |
| — | THIRD HARMONIC BIO INC | 2,015,301 | $8,666 | 3.6% | $4.30 | — | COM | 88427A107 |
| GLPG | GALAPAGOS NV-SPON ADR | 194,836 | $8,647 | 3.6% | $44.38 | — | SPON ADR | 36315X101 |
| EOLS | EVOLUS INC | 834,432 | $6,267 | 2.6% | $8.43 | -8.1% | COM | 30052C107 |
| RZLT | REZOLUTE INC | 3,021,504 | $6,255 | 2.6% | $3.92 | -52.2% | COM NEW | 76200L309 |
| CSTL | CASTLE BIOSCIENCES INC | 178,240 | $4,196 | 1.8% | $23.18 | 0.0% | COM | 14843C105 |
| — | CONFORMIS INC | 748,194 | $2,484 | 1.0% | $0.75 | — | COM | 20717E101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 108,769 | $2,121 | 0.9% | $19.77 | 0.0% | COM | 604749101 |
| XGN | EXAGEN INC | 854,042 | $2,050 | 0.9% | $11.52 | -77.7% | COM | 30068X103 |
| MXCT | MAXCYTE INC | 273,287 | $1,492 | 0.6% | $6.13 | 0.0% | COM | 57777K106 |
| OABI | OMNIAB INC | 354,266 | $1,275 | 0.5% | $5.33 | 0.0% | COM | 68218J103 |
| XOMA | XOMA CORP | 64,459 | $1,186 | 0.5% | $20.39 | -10.9% | COM NEW | 98419J206 |
| — | OPTINOSE INC | 508,284 | $940 | 0.4% | $1.62 | — | COM | 68404V100 |